Nahdi profit rises to SAR 830.7M in 2025, SAR 175.9M in Q4

09/03/2026 Argaam Exclusive

Content Summary:

Loading data...

Comments Analysis:

Positive: 0%
Neutral: 0%
Negative: 0%
Comments Summary:Loading data...
Please note that this news summary has been generated using artificial intelligence. It is recommended to review the original sources for complete details and to verify the accuracy of the information.

Nahdi Medical Co. reported a net profit of SAR 830.7 million for 2025, a 1.2% rise from SAR 820.7 million a year earlier.

 


Financials (M)

Item 2024 2025 Change‬
Revenues 9,446.42 10,213.20 8.1 %
Gross Income 3,512.30 3,805.60 8.4 %
Operating Income 873.20 926.50 6.1 %
Net Income 820.72 830.70 1.2 %
Average Shares 130.00 130.00 -
Earnings Per Share before unusual items (Riyals) 6.06 6.25 3.2 %
EPS (Riyal) 6.31 6.39 1.2 %

Revenue rose 8.1% in 2025 to SAR 10.2 billion compared with SAR 9.4 billion the previous year, driven by retail growth of 6.2% year-on-year (YoY) and strong performance in the healthcare and UAE retail segments.

 

Gross profit also increased 8.3% YoY to SAR 3.8 billion, while maintaining a steady gross margin of 37.3% despite continued investments in strategic initiatives.

 

In addition, operating profit rose by 6.1% YoY to SAR 926.5 million, supported by new pharmacy openings, expansion in healthcare and UAE retail, and digital transformation investments that partially offset higher operating expenses.

 

A reversal of a non-recurring Zakat provision of SAR 17.8 million was recorded in Q1 2025.

 

The profit rise was partially offset by SAR 43.3 million in other post-operating items, mainly due to higher bank charges and lease-related interest expenses linked to supporting sales growth and business expansion.



Current Quarter Comparison (M)

Compared With The
Item Q4 2024 Q4 2025 Change‬
Revenues 2,363.01 2,589.23 9.6 %
Gross Income 875.32 955.25 9.1 %
Operating Income 192.30 208.30 8.3 %
Net Income 157.85 175.88 11.4 %
Average Shares 130.00 130.00 -
Earnings Per Share before unusual items (Riyal) 1.21 1.35 11.4 %
EPS (Riyal) 1.21 1.35 11.4 %

Net earnings in Q4 2025 rose 11.4% YoY to SAR 175.9 million from SAR 157.8 million.

 

On a sequential basis, net earnings increased by 9.1% from SAR 161.2 million in Q3 2025.

 

Total shareholders’ equity, excluding minority interest, reached SAR 2.74 billion by Dec. 31, 2025, compared to SAR 2.58 billion in the prior-year period.

 

Attached Documents

 

View More Financial Results

 

View other reports

Share Price

Nahdi Medical Co.
103.20
1.00 0.98 %

Nahdi Medical Co. (NAHDI)

More


Financial Ratios
Current
Market Cap (M Riyal) 13,416.01
Enterprise Value (EV) (M Riyal) 12,862.01
Shares Outstanding ((M)) 130.00
EPS ( Riyal) (TTM) 6.39
Book Value (BV) ( Riyal) 21.10
Par Value ( Riyal) 10.00
Recurring P/E 16.50
P/E (TTM) 16.15
Price/book 4.89
Return on Average Assets (%) (TTM) 12.9
Return on Average Equity (%) (TTM) 31.2
EV/adj EBITDA -
EV/Revenues 1.26
more

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request